Christopher Bunka Lexaria Bioscience Corp. (LEXX) insider trading activity

LEXX Quotes by TradingView

Christopher Bunka is Director of Lexaria Bioscience Corp.. Currently has a direct ownership of 373,543 shares of LEXX, which is worth approximately $541,637. The most recent transaction as insider was on Jan 07, 2025, when has been sold 100,000 shares (Restricted Stock Award) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 374K
n/a 3M change
n/a 12M change
Total Value Held $541,637

CHRISTOPHER BUNKA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 07 2025
BUY
Grant, award, or other acquisition
-
100,000 Added 21.12%
373,543 Restricted Stock Award
CB

Christopher Bunka

Director
Kelowna, A1

Track Institutional and Insider Activities on LEXX

Follow Lexaria Bioscience Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LEXX shares.

Notify only if

Insider Trading

Get notified when an Lexaria Bioscience Corp. insider buys or sells LEXX shares.

Notify only if

News

Receive news related to Lexaria Bioscience Corp.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LEXX